PRODUCTS
« BACK TO "INTERNATIONAL"
Repaglinide is a carbamoylmethyl benzoic acid derivative, which lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas.
Repaglinide is indicated in patients with Type II diabetes.
| Active ingredient | Pharmaceutical form | Package | Therapeutic target |
|
|
|
|